Skip to content

MEPHARMA: what changed

BE 0827.027.443NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€60,000
2024 · €65,000-€5,000
Equity
€453,300
2024 · €393,300+€60,000
Cash
€239,479
2024 · €229,610+€9,869
Balance sheet total
€701,341
2024 · €684,404+€16,937

Largest movements

2024 to 2025
Assets
  • Cash +€9,869

    up €9,869 (+4.3%), from €229,610 to €239,479

    mainly Net result for the year (+€60,000) and Depreciation (+€8,282)

  • Receivables within one year +€9,296

    up €9,296 (+11.2%), from €82,849 to €92,145

    of which Trade receivables: +€8,522

Equity and liabilities
  • Reserves +€60,000

    up €60,000 (+15.5%), from €387,100 to €447,100

    of which Distributable reserves: +€60,000

  • Debts after one year -€29,115

    down €29,115 (-13.9%), from €210,130 to €181,016

  • Trade debts -€14,835

    down €14,835 (-25.8%), from €57,390 to €42,555

Income statement
  • Gross operating margin -€10,155

    down €10,155 (-5.2%), from €196,098 to €185,943

  • Taxes -€3,322

    down €3,322 (-11.9%), from €27,955 to €24,632

  • Financial charges -€3,188

    down €3,188 (-31.0%), from €10,297 to €7,109

  • Financial income +€2,791

    up €2,791 (+308%), from €907 to €3,698

  • Staff costs +€2,050

    up €2,050 (+2.4%), from €85,635 to €87,685

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result.

Result 2024 €65,000
Gross operating margin -€10,155
Staff costs -€2,050
Depreciation -€1,124
Provisions -€38
Other operating charges -€935
Financial income +€2,791
Financial charges +€3,188
Taxes +€3,322
Result 2025 €60,000
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€43,960
Investment -€4,976
Financing -€29,115
Cash 2024 €229,610
Net result for the year +€60,000
Depreciation +€8,282
Stocks and contracts -€1,326
Receivables within one year -€9,296
Deferred charges and accrued income +€249
Provisions +€270
Trade debts -€14,835
Tax, wage and social debts +€616
Investment in fixed assets (net) -€2,599
Current investments -€2,377
Debts after one year -€29,115
Cash 2025 €239,479
brings cash intakes cash out
Every line side by side 47 lines
Line Code 2024 2025 Change %
Total assets 20/58 €684,404 €701,341 +€16,937 +2.5%
Fixed assets 21/28 €31,615 €25,932 -€5,683 -18.0%
Tangible fixed assets 22/27 €31,615 €25,932 -€5,683 -18.0%
Plant, machinery and equipment 23 €22,965 €17,436 -€5,528 -24.1%
Furniture and vehicles 24 €8,650 €8,496 -€155 -1.8%
Current assets 29/58 €652,789 €675,409 +€22,620 +3.5%
Stocks and contracts in progress 3 €219,011 €220,337 +€1,326 +0.6%
Stocks 30/36 €219,011 €220,337 +€1,326 +0.6%
Amounts receivable within one year 40/41 €82,849 €92,145 +€9,296 +11.2%
Trade receivables 40 €82,534 €91,056 +€8,522 +10.3%
Other amounts receivable 41 €315 €1,089 +€774 +246%
Current investments 50/53 €109,893 €112,270 +€2,377 +2.2%
Cash at bank and in hand 54/58 €229,610 €239,479 +€9,869 +4.3%
Deferred charges and accrued income 490/1 €11,427 €11,178 -€249 -2.2%
Total equity and liabilities 10/49 €684,404 €701,341 +€16,937 +2.5%
Equity 10/15 €393,300 €453,300 +€60,000 +15.3%
Contributions 10/11 €6,200 €6,200 = 0.0%
Reserves 13 €387,100 €447,100 +€60,000 +15.5%
Non-distributable reserves 130/1 €1,860 €1,860 = 0.0%
Reserves not available under the articles 1311 €1,860 €1,860 = 0.0%
Distributable reserves 133 €385,240 €445,240 +€60,000 +15.6%
Provisions and deferred taxes 16 €8,753 €9,023 +€270 +3.1%
Provisions for liabilities and charges 160/5 €8,753 €9,023 +€270 +3.1%
Other liabilities and charges 164/5 €8,753 €9,023 +€270 +3.1%
Amounts payable 17/49 €282,351 €239,017 -€43,334 -15.3%
Amounts payable after more than one year 17 €210,130 €181,016 -€29,115 -13.9%
Financial debts 170/4 €210,130 €181,016 -€29,115 -13.9%
Amounts payable within one year 42/48 €72,221 €58,002 -€14,219 -19.7%
Trade debts 44 €57,390 €42,555 -€14,835 -25.8%
Suppliers 440/4 €57,390 €42,555 -€14,835 -25.8%
Taxes, remuneration and social security 45 €14,831 €15,447 +€616 +4.2%
Taxes 450/3 €6,812 €7,053 +€241 +3.5%
Remuneration and social security 454/9 €8,019 €8,394 +€375 +4.7%
Remuneration, social security and pensions 62 €85,635 €87,685 +€2,050 +2.4%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €7,158 €8,282 +€1,124 +15.7%
Provisions for liabilities and charges: additions (uses and reversals) 635/8 €232 €270 +€38 +16.5%
Other operating charges 640/8 €728 €1,662 +€935 +128%
Gross operating margin 9900 €196,098 €185,943 -€10,155 -5.2%
Operating profit (loss) 9901 €102,344 €88,043 -€14,301 -14.0%
Financial income 75/76B €907 €3,698 +€2,791 +308%
Recurring financial income 75 €907 €3,698 +€2,791 +308%
Financial charges 65/66B €10,297 €7,109 -€3,188 -31.0%
Recurring financial charges 65 €10,297 €7,109 -€3,188 -31.0%
Profit (loss) for the period before taxes 9903 €92,955 €84,632 -€8,322 -9.0%
Income taxes 67/77 €27,955 €24,632 -€3,322 -11.9%
Profit (loss) for the period 9904 €65,000 €60,000 -€5,000 -7.7%
Profit (loss) for the period to be appropriated 9905 €65,000 €60,000 -€5,000 -7.7%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Value of the equity

Indication, not a valuation or advice
€446,932 to €535,045

Midpoint €483,646 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate. Change the assumptions and the value follows.

Adjusted equity €453,300
Capitalised earnings €440,564 to €616,790
Indication €446,932 to €535,045

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€453,300
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€453,300

Capitalised earnings

net result for the year (9904)
2025
€60,000
2024
€65,000
2023
€60,036
2022
€69,195
excluding non-recurring income and charges
€75,195
2021
€60,500
Average result
€61,679
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€440,564 / €513,992 / €616,790

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 20 November 2026 via checked.be.